Reliance Global (EZRA) had the highest return between January 20, 2018 and January 26, 2018 by a US stock, returning 777,895.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Reliance Global (EZRA) | 1/20/2018 - 1/26/2018 | 777,895.17% |
Sobr Safe (SOBR) | 1/20/2018 - 1/26/2018 | 86.44% |
Oragenics (OGEN) | 1/20/2018 - 1/26/2018 | 50% |
Applied Digital (APLD) | 1/20/2018 - 1/26/2018 | 48.33% |
Myomo (MYO) | 1/20/2018 - 1/26/2018 | 47.49% |
Can Fite Biopharma Ltd ADR (CANF) | 1/20/2018 - 1/26/2018 | 42.94% |
Yarrow Bioscience (YARW) | 1/20/2018 - 1/26/2018 | 39.07% |
Anixa Biosciences (ANIX) | 1/20/2018 - 1/26/2018 | 38.13% |
World Acceptance (WRLD) | 1/20/2018 - 1/26/2018 | 37.48% |
NuCana (NCNA) | 1/20/2018 - 1/26/2018 | 34.84% |
Pulmatrix (PULM) | 1/20/2018 - 1/26/2018 | 32.67% |
VistaGen Therapeutics (VTGN) | 1/20/2018 - 1/26/2018 | 31.4% |
Rocket Pharmaceuticals (RCKT) | 1/20/2018 - 1/26/2018 | 30.1% |
TG Therapeutics (TGTX) | 1/20/2018 - 1/26/2018 | 30% |
Versus Systems Inc. (VS) | 1/20/2018 - 1/26/2018 | 29.99% |
vTv Therapeutics (VTVT) | 1/20/2018 - 1/26/2018 | 29.58% |
Zymeworks Inc Common Stock (ZYME) | 1/20/2018 - 1/26/2018 | 29.32% |
Capricor Therapeutics (CAPR) | 1/20/2018 - 1/26/2018 | 29.01% |
Gyre Therapeutics (GYRE) | 1/20/2018 - 1/26/2018 | 27.61% |
Skye Bioscience, Inc Common Stock (SKYE) | 1/20/2018 - 1/26/2018 | 27.41% |
Crispr Therapeutics (CRSP) | 1/20/2018 - 1/26/2018 | 27.26% |
Worksport (WKSP) | 1/20/2018 - 1/26/2018 | 26.67% |
FinVolution (FINV) | 1/20/2018 - 1/26/2018 | 26.08% |
Atara Biotherapeutics (ATRA) | 1/20/2018 - 1/26/2018 | 25.21% |
Atlas Lithium Corporation Common Stock (ATLX) | 1/20/2018 - 1/26/2018 | 25% |